Voriconazole suppresses the growth of Leishmania species in vitro

Successful Treatment of Old World Cutaneous Leishmaniasis Caused byLeishmania infantumwith Posaconazole

(2011) A. E. Paniz Mondolfi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents

(2011) Vijay K. Marrapu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents

(2011) Vijay K. Marrapu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized clinical trial

(2011) Maryam Emad et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Antileishmanial activity of benzocycloalkyl azole oximino ethers: The conformationally constraint analogues of oxiconazole

(2010) Aditya Verma et al.   ACTA TROPICA

Fibronectin Binding and Proteolytic Degradation by Leishmania and Effects on Macrophage Activation

(2008) M. M. Kulkarni et al.   INFECTION AND IMMUNITY